1-6 of 6
Francis Y. Lee
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Antitumor and Antiangiogenic Activities of BMS-690514, an Inhibitor of Human EGF and VEGF Receptor Kinase Families

Free
Tai W. Wong, Francis Y. Lee, Stuart Emanuel, Craig Fairchild, Joseph Fargnoli, Brian Fink, Ashvinikumar Gavai, Amy Hammell, Benjamin Henley, Christine Hilt, John T. Hunt, Bala Krishnan, Daniel Kukral, Anne Lewin, Harold Malone, Derek Norris, Simone Oppenheimer, Gregory Vite, Chiang Yu
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (12): 4031–4041.
https://doi.org/10.1158/1078-0432.CCR-10-3417
Published: 15 June 2011
View articletitled, Antitumor and Antiangiogenic Activities of BMS-690514, an Inhibitor of Human EGF and VEGF Receptor Kinase Families
Open the PDF for Antitumor and Antiangiogenic Activities of BMS-690514, an Inhibitor of Human EGF and VEGF Receptor Kinase Families in another window
Includes: Supplementary data
Journal Articles

Dasatinib Inhibits the Growth of Molecularly Heterogeneous Myeloid Leukemias

Free
Bella S. Guerrouahen, Muneyoshi Futami, Christos Vaklavas, Jukka Kanerva, Zakary L. Whichard, Kenechi Nwawka, Elisabeth G. Blanchard, Francis Y. Lee, Lisa J. Robinson, Robert Arceci, Steven M. Kornblau, Eric Wieder, Yvon E. Cayre, Seth J. Corey
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (4): 1149–1158.
https://doi.org/10.1158/1078-0432.CCR-09-2416
Published: 15 February 2010
View articletitled, Dasatinib Inhibits the Growth of Molecularly Heterogeneous Myeloid Leukemias
Open the PDF for Dasatinib Inhibits the Growth of Molecularly Heterogeneous Myeloid Leukemias in another window
Includes: Supplementary data
Journal Articles

Activities of SYK and PLCγ2 Predict Apoptotic Response of CLL Cells to SRC Tyrosine Kinase Inhibitor Dasatinib

Free
Zibo Song, Pin Lu, Richard R. Furman, John P. Leonard, Peter Martin, Lauren Tyrell, Francis Y. Lee, Daniel M. Knowles, Morton Coleman, Y. Lynn Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (2): 587–599.
https://doi.org/10.1158/1078-0432.CCR-09-1519
Published: 14 January 2010
View articletitled, Activities of SYK and PLCγ2 Predict Apoptotic Response of CLL Cells to SRC Tyrosine Kinase Inhibitor Dasatinib
Open the PDF for Activities of SYK and PLCγ2 Predict Apoptotic Response of CLL Cells to SRC Tyrosine Kinase Inhibitor Dasatinib in another window
Journal Articles

Dasatinib (BMS-354825) Pharmacokinetics and Pharmacodynamic Biomarkers in Animal Models Predict Optimal Clinical Exposure

Free
Feng R. Luo, Zheng Yang, Amy Camuso, Richard Smykla, Kelly McGlinchey, Krista Fager, Christine Flefleh, Stephen Castaneda, Ivan Inigo, David Kan, Mei-Li Wen, Robert Kramer, Anne Blackwood-Chirchir, Francis Y. Lee
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (23): 7180–7186.
https://doi.org/10.1158/1078-0432.CCR-06-1112
Published: 04 December 2006
View articletitled, Dasatinib (BMS-354825) Pharmacokinetics and Pharmacodynamic Biomarkers in Animal Models Predict Optimal Clinical Exposure
Open the PDF for Dasatinib (BMS-354825) Pharmacokinetics and Pharmacodynamic Biomarkers in Animal Models Predict Optimal Clinical Exposure in another window
Journal Articles

Preclinical Antitumor Activity of BMS-599626, a pan-HER Kinase Inhibitor That Inhibits HER1/HER2 Homodimer and Heterodimer Signaling

Free
Tai W. Wong, Francis Y. Lee, Chiang Yu, Feng R. Luo, Simone Oppenheimer, Hongjian Zhang, Richard A. Smykla, Harold Mastalerz, Brian E. Fink, John T. Hunt, Ashvinikumar V. Gavai, Gregory D. Vite
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (20): 6186–6193.
https://doi.org/10.1158/1078-0432.CCR-06-0642
Published: 24 October 2006
View articletitled, Preclinical Antitumor Activity of BMS-599626, a pan-HER Kinase Inhibitor That Inhibits HER1/HER2 Homodimer and Heterodimer Signaling
Open the PDF for Preclinical Antitumor Activity of BMS-599626, a pan-HER Kinase Inhibitor That Inhibits HER1/HER2 Homodimer and Heterodimer Signaling in another window
Journal Articles

Prediction of Active Drug Plasma Concentrations Achieved in Cancer Patients by Pharmacodynamic Biomarkers Identified from the Geo Human Colon Carcinoma Xenograft Model

Free
Feng R. Luo, Zheng Yang, Huijin Dong, Amy Camuso, Kelly McGlinchey, Krista Fager, Christine Flefleh, David Kan, Ivan Inigo, Stephen Castaneda, Tai W. Wong, Robert A. Kramer, Robert Wild, Francis Y. Lee
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (15): 5558–5565.
https://doi.org/10.1158/1078-0432.CCR-05-0368
Published: 01 August 2005
View articletitled, Prediction of Active Drug Plasma Concentrations Achieved in Cancer Patients by Pharmacodynamic Biomarkers Identified from the Geo Human Colon Carcinoma Xenograft Model
Open the PDF for Prediction of Active Drug Plasma Concentrations Achieved in Cancer Patients by Pharmacodynamic Biomarkers Identified from the Geo Human Colon Carcinoma Xenograft Model in another window